Literature DB >> 34035736

Current Status of the Use of Statins and Aspirin in the Chemoprevention of Hepatocellular Carcinoma.

Yujin Hoshida1.   

Abstract

Entities:  

Year:  2020        PMID: 34035736      PMCID: PMC8132708     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN: 1554-7914


× No keyword cloud information.
  7 in total

1.  Lipophilic Statins and Risk for Hepatocellular Carcinoma and Death in Patients With Chronic Viral Hepatitis: Results From a Nationwide Swedish Population.

Authors:  Tracey G Simon; Ann-Sofi Duberg; Soo Aleman; Hannes Hagstrom; Long H Nguyen; Hamed Khalili; Raymond T Chung; Jonas F Ludvigsson
Journal:  Ann Intern Med       Date:  2019-08-20       Impact factor: 25.391

2.  Association of Aspirin with Hepatocellular Carcinoma and Liver-Related Mortality.

Authors:  Tracey G Simon; Ann-Sofi Duberg; Soo Aleman; Raymond T Chung; Andrew T Chan; Jonas F Ludvigsson
Journal:  N Engl J Med       Date:  2020-03-12       Impact factor: 91.245

3.  Platelet GPIbα is a mediator and potential interventional target for NASH and subsequent liver cancer.

Authors:  Mohsen Malehmir; Dominik Pfister; Suchira Gallage; Marta Szydlowska; Donato Inverso; Elena Kotsiliti; Valentina Leone; Moritz Peiseler; Bas G J Surewaard; Dominik Rath; Adnan Ali; Monika Julia Wolf; Hannah Drescher; Marc E Healy; Daniel Dauch; Daniela Kroy; Oliver Krenkel; Marlene Kohlhepp; Thomas Engleitner; Alexander Olkus; Tjeerd Sijmonsma; Julia Volz; Carsten Deppermann; David Stegner; Patrick Helbling; César Nombela-Arrieta; Anahita Rafiei; Martina Hinterleitner; Marcel Rall; Florian Baku; Oliver Borst; Caroline L Wilson; Jack Leslie; Tracy O'Connor; Christopher J Weston; Abhishek Chauhan; David H Adams; Lozan Sheriff; Ana Teijeiro; Marco Prinz; Ruzhica Bogeska; Natasha Anstee; Malte N Bongers; Mike Notohamiprodjo; Tobias Geisler; Dominic J Withers; Jerry Ware; Derek A Mann; Hellmut G Augustin; Alexandros Vegiopoulos; Michael D Milsom; Adam J Rose; Patricia F Lalor; Josep M Llovet; Roser Pinyol; Frank Tacke; Roland Rad; Matthias Matter; Nabil Djouder; Paul Kubes; Percy A Knolle; Kristian Unger; Lars Zender; Bernhard Nieswandt; Meinrad Gawaz; Achim Weber; Mathias Heikenwalder
Journal:  Nat Med       Date:  2019-04-01       Impact factor: 53.440

4.  Dose and Duration of Aspirin Use to Reduce Incident Hepatocellular Carcinoma.

Authors:  Naoto Fujiwara; Amit G Singal; Yujin Hoshida
Journal:  Hepatology       Date:  2019-08-07       Impact factor: 17.298

Review 5.  Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine.

Authors:  Naoto Fujiwara; Scott L Friedman; Nicolas Goossens; Yujin Hoshida
Journal:  J Hepatol       Date:  2017-10-06       Impact factor: 30.083

Review 6.  Generic chemoprevention of hepatocellular carcinoma.

Authors:  Sai Krishna Athuluri-Divakar; Yujin Hoshida
Journal:  Ann N Y Acad Sci       Date:  2018-09-17       Impact factor: 6.499

Review 7.  Statin Use and the Risk of Hepatocellular Carcinoma: A Meta-Analysis of Observational Studies.

Authors:  Md Mohaimenul Islam; Tahmina Nasrin Poly; Bruno Andreas Walther; Hsuan-Chia Yang; Yu-Chuan Jack Li
Journal:  Cancers (Basel)       Date:  2020-03-13       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.